skip to main content

coh-msn-Altered immune response

Altered Immune Response –

A) Overview of Normal Immune System

  • Innate Immunity (Non-specific): First line of defense (skin, mucous membranes, phagocytes).
  • Adaptive Immunity (Specific): Long-term defense; includes B cells (antibodies: IgG, IgA, IgM, IgE, IgD) and T cells (CD4, CD8).
  • Key Organs: Bone marrow, thymus, lymph nodes, spleen.

B) Altered Immune Response, Hypersensitivity, and Allergy

  • Altered Immune Response: Overactive (hypersensitivity), underactive (immunodeficiency), or misguided (autoimmunity).
  • Hypersensitivity Types (Gell & Coombs Classification):
    1. Type I (Immediate/IgE): Anaphylaxis, asthma, allergies.
    2. Type II (Cytotoxic/IgG, IgM): Hemolytic anemia, transfusion reactions.
    3. Type III (Immune Complex): Lupus, serum sickness.
    4. Type IV (Delayed/T-cell mediated): Contact dermatitis, TB test.
  • Allergy: Exaggerated response to allergens like pollen, dust, foods.

C) Assessment of the Immune System

  • History: Recurrent infections, autoimmune conditions, allergy history.
  • Physical Exam: Rashes, swollen lymph nodes, respiratory issues, signs of infection.

D) Diagnostic Evaluation

  • Blood Tests: CBC with differential, immunoglobulin levels (↑IgE = allergies), autoantibodies (ANA, RF).
  • Skin Tests: Allergy skin prick, Mantoux (TB) test.
  • Advanced Tests: Complement levels (C3, C4), Flow cytometry (HIV), ELISA (HIV antibodies).

🚨 Last-Minute Quick Facts (High-Yield for Exams):

  • Type I Hypersensitivity β†’ IgE-mediated β†’ Anaphylaxis risk
  • Autoimmune diseases β†’ Positive ANA (SLE), RF (RA)
  • IgE ↑ in allergies; IgG, IgM ↑ in infections
  • ELISA β†’ Used for HIV diagnosis
  • Type IV hypersensitivity β†’ Delayed reaction β†’ TB test

Allergic Disorders for Competitive Nursing Exams

1. Anaphylaxis (Life-Threatening Emergency)

  • Definition: A severe, rapid, systemic allergic reaction causing airway obstruction and shock.
  • Causes: Food (nuts, shellfish), insect stings, drugs (penicillin), latex.
  • Pathophysiology: IgE-mediated (Type I Hypersensitivity) β†’ Mast cell degranulation β†’ Histamine release β†’ Vasodilation, bronchoconstriction.
  • Symptoms:
    • Skin: Urticaria (hives), angioedema
    • Respiratory: Wheezing, stridor, dyspnea
    • Cardiovascular: Hypotension, tachycardia
    • Gastrointestinal: Nausea, vomiting
  • Management:
    • First-line: Epinephrine IM (0.3–0.5 mg) immediately
    • Supportive care: Oxygen, IV fluids, antihistamines, corticosteroids
  • Key Word: Epinephrine – Drug of Choice

2. Allergic Rhinitis (“Hay Fever”)

  • Definition: Inflammation of nasal mucosa due to allergens (pollen, dust, pet dander).
  • Pathophysiology: Type I Hypersensitivity β†’ IgE-mediated histamine release.
  • Symptoms: Sneezing, runny/stuffy nose, itchy eyes, postnasal drip.
  • Management:
    • Avoid triggers
    • Antihistamines (Loratadine, Cetirizine)
    • Nasal corticosteroids (Fluticasone)
  • Key Word: Seasonal or Perennial Allergy

3. Contact Dermatitis

  • Definition: Inflammatory skin reaction due to contact with allergens or irritants.
  • Types:
    • Irritant Contact Dermatitis: Non-immune reaction (e.g., chemicals, detergents).
    • Allergic Contact Dermatitis: Type IV Hypersensitivity (delayed) to allergens (e.g., nickel, poison ivy).
  • Symptoms: Red, itchy rash, blisters, dry skin at contact site.
  • Management:
    • Avoid irritants
    • Topical corticosteroids
    • Moisturizers
  • Key Word: Delayed Reaction – Type IV

4. Atopic Dermatitis (Eczema)

  • Definition: Chronic, relapsing inflammatory skin condition with genetic predisposition.
  • Pathophysiology: Associated with atopy (asthma, allergic rhinitis) and Type I Hypersensitivity.
  • Symptoms: Dry, itchy, red skin, often in skin folds (elbows, knees).
  • Management:
    • Emollients (moisturizers)
    • Topical steroids for inflammation
    • Antihistamines for itching
  • Key Word: “Itch-Scratch Cycle”

5. Drug Reactions (Drug Hypersensitivity)

  • Definition: Adverse immune response to medications.
  • Types:
    • Type I (Immediate): Urticaria, anaphylaxis (common with penicillin).
    • Type II: Hemolytic anemia (e.g., methyldopa).
    • Type III: Serum sickness-like reaction.
    • Type IV: Stevens-Johnson syndrome, contact dermatitis.
  • Management:
    • Stop the offending drug
    • Epinephrine for anaphylaxis
    • Antihistamines, corticosteroids
  • Key Word: Stevens-Johnson Syndrome = Medical Emergency

6. Food Allergy

  • Definition: Immune reaction to specific foods (nuts, shellfish, eggs, milk).
  • Pathophysiology: Type I Hypersensitivity (IgE-mediated).
  • Symptoms:
    • Mild: Hives, itching, GI upset
    • Severe: Anaphylaxis (breathing difficulty, hypotension)
  • Management:
    • Avoid trigger foods
    • Epinephrine auto-injector (EpiPen) for emergencies
  • Key Word: Peanuts – Most Common Trigger

7. Serum Sickness

  • Definition: A Type III Hypersensitivity reaction to foreign proteins (e.g., antiserum, some drugs like penicillin).
  • Pathophysiology: Immune complex formation β†’ complement activation β†’ inflammation.
  • Symptoms: Fever, rash, joint pain, lymphadenopathy, occurring 1–2 weeks after exposure.
  • Management:
    • Stop the triggering agent
    • Antihistamines, corticosteroids
  • Key Word: “Immune Complex-Mediated Reaction”

8. Latex Allergy

  • Definition: Allergic reaction to natural rubber latex.
  • Pathophysiology:
    • Type I Hypersensitivity (IgE-mediated): Immediate reaction (anaphylaxis risk).
    • Type IV Hypersensitivity: Delayed skin reaction (contact dermatitis).
  • Symptoms:
    • Mild: Rash, itching
    • Severe: Urticaria, angioedema, anaphylaxis
  • Management:
    • Avoid latex products
    • Use latex-free gloves and equipment
    • Epinephrine for severe reactions
  • Key Word: High Risk in Healthcare Workers

🚨 Quick Revision (High-Yield Points):

  • Anaphylaxis = IgE-mediated β†’ Treat with Epinephrine
  • Allergic Rhinitis = Antihistamines + Avoid triggers
  • Contact Dermatitis = Type IV Hypersensitivity (Delayed)
  • Atopic Dermatitis = Itchy, Chronic, Eczema β†’ Moisturizers + Steroids
  • Drug Reactions = Stop drug immediately, treat symptoms
  • Food Allergy = EpiPen for severe reactions
  • Serum Sickness = Type III Reaction (Immune Complexes)
  • Latex Allergy = Healthcare Workers at Risk β†’ Latex-free products

Approaches to Treat Allergic Diseases, Nursing Management, and Autoimmune Diseases

(High-Yield for Competitive Nursing Exams)

F) Approaches to Treat Allergic Diseases

1. Allergen Avoidance:

  • Identify and avoid triggers (dust, pollen, food, latex).
  • Use air purifiers, dust-proof covers, hypoallergenic products.

2. Pharmacological Therapy:

  • Antihistamines: For mild allergic reactions (e.g., loratadine, cetirizine).
  • Corticosteroids: Reduce inflammation (e.g., nasal sprays for rhinitis, topical creams for dermatitis).
  • Decongestants: For nasal congestion (e.g., pseudoephedrine).
  • Leukotriene Modifiers: (e.g., montelukast) for asthma and allergic rhinitis.
  • Epinephrine: First-line drug for anaphylaxis (IM route).

3. Immunotherapy (Allergy Shots):

  • Gradual desensitization by exposing to small amounts of allergens over time.

4. Biologic Therapies:

  • Monoclonal antibodies (e.g., omalizumab) for severe asthma and chronic urticaria.

5. Emergency Measures (Anaphylaxis):

  • Epinephrine auto-injector (EpiPen)
  • Oxygen therapy, IV fluids, and airway management if needed.

G) Nursing Management of Clients with Altered Immune Response

1. Assessment:

  • Detailed history (allergies, autoimmune conditions, recurrent infections).
  • Physical exam: Skin changes, respiratory status, lymph node enlargement.

2. Diagnosis:

  • Risk for anaphylaxis, impaired skin integrity, ineffective airway clearance, activity intolerance.

3. Planning and Implementation:

  • Ensure Airway, Breathing, Circulation (ABCs) in emergencies.
  • Administer prescribed medications (epinephrine, antihistamines, corticosteroids).
  • Monitor for signs of anaphylaxis: wheezing, hypotension, urticaria.
  • Educate patient on allergen avoidance and use of EpiPen.
  • Infection prevention measures for immunocompromised patients (hand hygiene, avoid crowds).

4. Evaluation:

  • Improved breathing, reduced allergic symptoms, no recurrence of severe reactions.

H) Autoimmune Diseases

Autoimmune diseases occur when the immune system attacks the body’s own cells.

1. Rheumatoid Arthritis (RA):

  • Definition: Chronic systemic autoimmune disease causing joint inflammation.
  • Pathophysiology: Type III Hypersensitivity reaction; immune complexes deposit in joints.
  • Symptoms: Joint pain, stiffness (especially morning), swelling, fatigue.
  • Diagnosis: Positive Rheumatoid Factor (RF), anti-CCP antibodies, elevated ESR, CRP.
  • Management:
    • Medications: NSAIDs, corticosteroids, DMARDs (methotrexate), biologics (infliximab).
    • Physical therapy: To maintain joint mobility.
    • Nursing Care: Pain management, joint protection techniques.

2. Systemic Lupus Erythematosus (SLE):

  • Definition: Chronic autoimmune disease affecting skin, joints, kidneys, brain.
  • Symptoms: Butterfly-shaped rash, joint pain, fatigue, photosensitivity, kidney involvement.
  • Diagnosis: Positive ANA (Antinuclear Antibody) test, low complement levels, elevated ESR.
  • Management:
    • Medications: NSAIDs, corticosteroids, immunosuppressants (azathioprine), antimalarials (hydroxychloroquine).
    • Avoid sunlight, manage stress, regular follow-ups.
  • Nursing Care: Skin care, infection prevention, fatigue management.

3. Ankylosing Spondylitis:

  • Definition: Chronic inflammatory disease affecting the spine and sacroiliac joints.
  • Symptoms: Lower back pain, stiffness, reduced spinal mobility, “bamboo spine” on X-ray.
  • Diagnosis: HLA-B27 antigen positive, X-ray changes.
  • Management:
    • Medications: NSAIDs, TNF inhibitors (etanercept), physical therapy.
    • Exercise: Posture correction, back-strengthening exercises.
  • Nursing Care: Pain relief, mobility exercises, posture education.

4. Graft Versus Host Disease (GVHD):

  • Definition: A complication after bone marrow or stem cell transplant where donor immune cells attack the recipient’s body.
  • Types:
    • Acute GVHD: Occurs within 100 days post-transplant (skin rash, liver dysfunction, GI issues).
    • Chronic GVHD: Occurs later, affecting multiple organs.
  • Symptoms: Skin rash, diarrhea, jaundice, dry eyes/mouth.
  • Management:
    • Immunosuppressive drugs: Corticosteroids, cyclosporine.
    • Supportive care: Skin moisturizers, nutritional support.
  • Nursing Care: Infection prevention, monitoring for signs of organ involvement, medication adherence.

🚨 High-Yield Quick Facts:

  • Anaphylaxis = Epinephrine IM is the first-line treatment.
  • Rheumatoid Arthritis = Positive RF and anti-CCP antibodies.
  • SLE = Butterfly rash + Positive ANA test.
  • GVHD = Complication after bone marrow transplant β†’ Managed with immunosuppressants.
  • Ankylosing Spondylitis = Bamboo spine on X-ray, HLA-B27 positive.

Published
Categorized as COH-MSN, Uncategorised